The researcher’ goal was to ascertain whether patients with heart failure with reduced ejection fraction due to nonischemic etiology who are eligible for cardiac resynchronization therapy can benefit from an ICD.
The researchers’ aim was to determine the demographics, angiographic findings, and in-hospital outcomes of COVID-19 ACS patients and compare these with pre-COVID-19 cohorts.
The COVID-19 epidemic has highlighted disparities in hypertension control in the United States.
The researchers’ goal was to study the incidence and impact of major in-hospital bleeding on all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock who undergo PCI.
Investigators adapted a simple compartmental epidemic model to simulate SARS-CoV-2 spread, death, and associated costs in the US in an effort to understand the role of at home testing.
The researchers sought to characterize the relationship between inflammatory markers and baseline, maximum, and change in troponin levels.
Elevated troponin-I levels were linked to clinical trajectory in a cohort of hospitalized patients with COVID-19.
Researchers aimed to study the associations between heart failure medications and certain systemic autoimmune rheumatic diseases.
The investigators sought to determine the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention.
In a review and meta-analysis, investigators evaluated the novel fatty acid inhibitor bempedoic acid as a possible treatment for hyperlipidemia.
